Edu Suarez completed her Ph.D. in Biomedical Sciences at Ponce School of Medicine (PR). She is a faculty member at the Department of Biology of the University of Puerto Rico-Ponce since 2004. The last 12 years Prof. Suarez acts as Program Director for an NIH undergraduate training grant to increase Biomedical Research in underrepresented populations. Dr. Suarez studied breast cancer at molecular/celular levels, searching for novel tratments including calcium sulfide nanoclusters. Most recently, her passion for reaching out to the community coupled with the Pink Luminous Advocacy Project (Silk-Pro,USA), leading her to seek and evaluate innovating breast cancer diagnostic devices.
University of Genoa
Katia Cortese has completed her PhD at the age of 27 years from University of Milan and postdoctoral studies from University of Queensland, Institute for Molecular Bioscience, Brisbane (AUS). She is Associate Professor of Human Anatomy at the University of Genoa, Department of Experimental Medicine and Head of the Cellular Electron Microscopy Lab, that is mainly interested in cellular and ultrastructural oncology research. So far, she has published 68 papers in reputed journals and has been serving as an editorial board member of BMC cancer and Membranes journals.
Yale School of Medicine
Young Choi, M.D., graduated from Seoul National College of Medicine, South Korea in 1966, and completed Anatomic and Clinical Pathology training in academic medical centers in the USA. She was appointed Chair of Pathology and Lab Director at the major academic medical centers in New York and CT, and lastly as vice-Chair of Pathology at the Yale School of Medicine, New Haven, CT. She published over 30 peer-reviewed research articles and presented research abstracts on breast cancers at various scientific meetings for the last 30 years. She has served as the editor at the AIMM.
Jun Liang received his Ph.D from Harvard University under the supervision of Prof. Andrew G. Myers. He is currently a Distinguished Principal Scientist at Discovery Chemistry Dept, at Genenetch, which he joined in 2005. Before Genentech, Jun worked at Merck Research Lab from 2000-2005. His research focused on drug discovery of various targets for oncology, cancer immunotherapy, immunolgy, CNS, and infectious disease.